Advisory Resource Group Boosts Stock Position in Danaher Co. (NYSE:DHR)

Advisory Resource Group increased its stake in Danaher Co. (NYSE:DHRGet Rating) by 21.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,337 shares of the conglomerate’s stock after buying an additional 240 shares during the quarter. Advisory Resource Group’s holdings in Danaher were worth $382,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of DHR. BlackRock Inc. lifted its position in Danaher by 3.1% in the third quarter. BlackRock Inc. now owns 45,621,495 shares of the conglomerate’s stock worth $13,889,008,000 after buying an additional 1,360,659 shares during the last quarter. UBS Asset Management Americas Inc. lifted its position in Danaher by 31.6% in the third quarter. UBS Asset Management Americas Inc. now owns 4,923,603 shares of the conglomerate’s stock worth $1,498,942,000 after buying an additional 1,181,343 shares during the last quarter. Two Sigma Advisers LP bought a new stake in Danaher in the third quarter worth $336,954,000. Morgan Stanley lifted its position in Danaher by 4.6% in the third quarter. Morgan Stanley now owns 14,362,364 shares of the conglomerate’s stock worth $4,372,479,000 after buying an additional 635,346 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC bought a new stake in Danaher in the fourth quarter worth $190,087,000. Institutional investors own 82.84% of the company’s stock.

Danaher stock traded down $5.87 during mid-day trading on Friday, hitting $251.13. The company had a trading volume of 3,225,216 shares, compared to its average volume of 2,868,812. The company has a current ratio of 1.68, a quick ratio of 1.27 and a debt-to-equity ratio of 0.51. Danaher Co. has a 12-month low of $238.32 and a 12-month high of $333.96. The company’s fifty day moving average is $277.46 and its 200-day moving average is $293.71. The company has a market capitalization of $182.59 billion, a price-to-earnings ratio of 29.07, a P/E/G ratio of 2.79 and a beta of 0.78.

Danaher (NYSE:DHRGet Rating) last released its quarterly earnings data on Thursday, April 21st. The conglomerate reported $2.76 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.66 by $0.10. Danaher had a return on equity of 18.64% and a net margin of 21.32%. The business had revenue of $7.69 billion for the quarter, compared to analyst estimates of $7.53 billion. During the same quarter in the prior year, the firm posted $2.52 EPS. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. As a group, sell-side analysts expect that Danaher Co. will post 10.37 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, April 29th. Stockholders of record on Friday, March 25th were given a dividend of $0.25 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.21. The ex-dividend date was Thursday, March 24th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.40%. Danaher’s dividend payout ratio (DPR) is 11.57%.

A number of analysts recently issued reports on the company. Barclays lowered their price target on Danaher from $355.00 to $325.00 and set an “overweight” rating for the company in a research report on Thursday, January 27th. William Blair reaffirmed an “outperform” rating on shares of Danaher in a research note on Friday, April 22nd. Zacks Investment Research lowered shares of Danaher from a “buy” rating to a “hold” rating and set a $278.00 price target for the company. in a research report on Monday, April 25th. Royal Bank of Canada cut their price objective on shares of Danaher from $311.00 to $299.00 and set a “sector perform” rating on the stock in a report on Friday, April 22nd. Finally, StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Friday, April 22nd. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $331.14.

In other news, SVP Brian W. Ellis sold 5,365 shares of the stock in a transaction that occurred on Wednesday, February 2nd. The stock was sold at an average price of $293.99, for a total transaction of $1,577,256.35. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Joakim Weidemanis sold 6,500 shares of the stock in a transaction that occurred on Monday, April 25th. The shares were sold at an average price of $255.74, for a total value of $1,662,310.00. Following the transaction, the executive vice president now owns 86,398 shares in the company, valued at approximately $22,095,424.52. The disclosure for this sale can be found here. Insiders have sold a total of 32,373 shares of company stock worth $9,089,268 in the last quarter. Insiders own 11.20% of the company’s stock.

About Danaher (Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRGet Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.